Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

E.J Lewis, L.G Hunsicker, W.R Clarkeet al

Open source

DOI
10.1016/s1062-1458(01)00550-5
Published
2002-01
Container
ACC Current Journal Review
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1062-1458-01-00550-5,
  title = {Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes},
  author = {E.J Lewis and L.G Hunsicker and W.R Clarkeet al},
  year = {2002},
  journal = {ACC Current Journal Review},
  doi = {10.1016/s1062-1458(01)00550-5},
  url = {https://doi.org/10.1016/s1062-1458(01)00550-5}
}

RIS

TY  - JOUR
TI  - Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
AU  - E.J Lewis
AU  - L.G Hunsicker
AU  - W.R Clarkeet al
PY  - 2002
JO  - ACC Current Journal Review
DO  - 10.1016/s1062-1458(01)00550-5
UR  - https://doi.org/10.1016/s1062-1458(01)00550-5
ER  - 

APA

Lewis, E., Hunsicker, L., & al, W. C. (2002). Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. ACC Current Journal Review. https://doi.org/10.1016/s1062-1458(01)00550-5

Source records